MedRhythms, in collaboration with Boston University, is launching a clinical trial of its pipeline asset MR-005 in Parkinson’s disease (PD).
In addition, the company is expanding its pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms’ announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs.
MedRhythms, headquartered in Portland, Me, is a digital therapeutics company that builds direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury.
MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson s Disease and Expands Pipeline to Aging
News provided by
Share this article
Share this article
PORTLAND, Maine, April 13, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the initiation of a multi-site clinical trial, in collaboration with Boston University and one of the world s leading hospitals, of its pipeline asset MR-005 in Parkinson s disease (PD) as well as the expansion of the company s pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs.
Siskin Hospital Receives Accreditation For Post-Professional Residency Program Wednesday, December 16, 2020
Siskin Hospital announces its Neurologic Physical Therapy Residency Program has received five-year accreditation status.
The accreditation is issued by the American Board of Physical Therapy Residency and Fellowship Education following a recent program survey.
“We’re honored to provide a post-professional education program like this at Siskin Hospital,” said President and CEO Dr. Matt Gibson. “One-on-one mentoring and guided learning of the next generation of physical therapists will ensure the highest quality of patient care continues to be available in our region.”
The Siskin Hospital for Physical Rehabilitation Neurologic Residency Program provides advanced education and clinical experience to physical therapists in the field of neurology in order to promote improved patient care and outcomes, ground advanced clinicians in the field of neurologic physic